E-LIB Suche - Ergebnisse für: Vogel, Arndt

1

THU-464 aMAP score predicts progression-free survival in pa..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia...
Journal of Hepatology. 80 (2024) - p. S443 , 2024

Link: https://doi.org/10.1016/..

2

O-10 VALIDATION OF SERUM BIOMARKER PANELS FOR EARLY HCC DET..:

Beudeker, Boris ; Fu, Siyu ; Balderramo, Domingo...
Annals of Hepatology. 29 (2024) - p. 101260 , 2024

Link: https://doi.org/10.1016/..

3

A meta-analysis and real-world cohort study on the sex-rela..:

Balcar, Lorenz ; Scheiner, Bernhard ; Fulgenzi, Claudia Angela Maria...
JHEP Reports. 6 (2024) 2 - p. 100982 , 2024

Link: https://doi.org/10.1016/..

4

Tu1578 IMBRAVE150: EXPLORATORY EFFICACY AND SAFETY RESULTS ..:

Finn, Richard S. ; Breder, Valeriy ; Vogel, Arndt...
Gastroenterology. 166 (2024) 5 - p. S-1738 , 2024

Link: https://doi.org/10.1016/..

5

Molecular profiling in cholangiocarcinoma: A practical guid..:

Stenzinger, Albrecht ; Vogel, Arndt ; Lehmann, Ulrich...
Cancer Treatment Reviews. 122 (2024) - p. 102649 , 2024

Link: https://doi.org/10.1016/..

6

Evidence and Choice: The BCLC Vision for Tailoring Clinical..:

Reig, Maria ; Forner, Alejandro ; Rimola, Jordi...
Journal of Hepatology. , 2024

Link: https://doi.org/10.1016/..

7

Dynamic YAP expression in the non-parenchymal liver cell co..:

Liu, Kaijing ; Wehling, Lilija ; Wan, Shan...
Cellular and Molecular Life Sciences. 81 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

8

Nanoliposomal irinotecan and fluorouracil plus leucovorin v..:

Vogel, Arndt ; Saborowski, Anna ; Wenzel, Patrick...
The Lancet Gastroenterology & Hepatology. 9 (2024) 8 - p. 734-744 , 2024

Link: https://doi.org/10.1016/..

9

THU-470-YI Analysis of treatment benefits and prognostic fa..:

Li, Zhihao ; Chen, Itsuko Chih-Yi ; O'Kane, Grainne...
Journal of Hepatology. 80 (2024) - p. S445 , 2024

Link: https://doi.org/10.1016/..

10

Safety profile of pembrolizumab monotherapy based on an agg..:

Brahmer, Julie R. ; Long, Georgina V. ; Hamid, Omid...
European Journal of Cancer. 199 (2024) - p. 113530 , 2024

Link: https://doi.org/10.1016/..

11

Characteristics and outcomes of immunotherapy-related liver..:

Celsa, Ciro ; Cabibbo, Giuseppe ; Fulgenzi, Claudia A.M....
Journal of Hepatology. 80 (2024) 3 - p. 431-442 , 2024

Link: https://doi.org/10.1016/..

12

Tislelizumab versus Sorafenib in First-Line Treatment of Un..:

Finn, Richard S. ; Kudo, Masatoshi ; Barnes, Gisoo...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

13

Characterization of Tumor Responses in Patients with Unrese..:

Finn, Richard S. ; Qin, Shukui ; Piscaglia, Fabio...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

14

THU-471-YI From randomised clinical trials to clinical prac..:

Manfredi, Giulia Francesca ; Fulgenzi, Claudia ; Celsa, Ciro...
Journal of Hepatology. 80 (2024) - p. S445-S446 , 2024

Link: https://doi.org/10.1016/..

15

Durvalumab plus gemcitabine and cisplatin in advanced bilia..:

Burris III, Howard A ; Okusaka, Takuji ; Vogel, Arndt...
The Lancet Oncology. 25 (2024) 5 - p. 626-635 , 2024

Link: https://doi.org/10.1016/..